Welcome!

Cognitive Computing Authors: Elizabeth White, Pat Romanski, Liz McMillan, Yeshim Deniz, Shelly Palmer

News Feed Item

Global Sleep Apnea Diagnostic And Therapeutic Devices Industry

NEW YORK, Dec. 4, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Sleep Apnea Diagnostic And Therapeutic Devices Industry

http://www.reportlinker.com/p01048443/Global-Sleep-Apnea-Diagnostic--And...

This report analyzes the worldwide markets for Sleep Apnea Diagnostic and Therapeutic Devices in US$ Million by the following Product Segments: Diagnostic Devices (Fixed PSG, Ambulatory PSG, & Others (include Screening Devices)), and Therapeutic Devices (CPAP, Bi-Level PAP, Auto PAP, & Facial Interfaces (Masks and Humidifiers)). The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. A six-year historic analysis is also provided for these markets. The report profiles 68 companies including many key and niche players such as Grass Technologies, Cadwell Laboratories, Inc., CareFusion Corporation, Compumedics Ltd., DeVilbiss Healthcare, Global Medical Holdings LLC, Fisher & Paykel Healthcare Limited, GE Healthcare, Vital Signs Inc., Itamar Medical Ltd., Invacare Corporation, Natus Medical Inc., Bio-Logic, Embla Systems, Inc., Stellate Systems, Inc., Philips Healthcare, ResMed Inc., Teleflex Medical, and Weinmann Geräte für Medizin GmbH+CCo. KG. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONSStudy Reliability and Reporting Limitations I-1Disclaimers I-2Data Interpretation & Reporting Level I-2Quantitative Techniques & Analytics I-3Product Definitions and Scope of Study I-3Diagnostic Devices I-3Fixed PSG I-3Ambulatory PSG I-3Others (include Screening Devices) I-3Therapeutic Devices I-4CPAP I-4Bi-Level PAP I-4Auto PAP I-4Facial Interfaces (Masks and Humidifiers) I-4II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW II-1

Current & Future Analysis II-1

Prevalence Statistics II-1

The US is the Clear Market Leader, Developing Regions Promise

Growth II-2

Segmental Analysis II-2

2. MARKET DYNAMICS II-3Impact of Economic Recession on the Medical Device Industry II-3Emergence of Dental Sleep Medicine II-3Sleep Apnea/Sleep Disorders in Children Responsible for Obesity II-3Changing Demographics to Play a Major Role II-4Increased Awareness of Comorbid Conditions Spurs Market Growth II-4Demerits of Present Diagnostic Procedures II-4Technology Advancements Improve Patient Compliance II-4Automated CPAP II-5Humidification II-5Patient-Friendly Masks II-5Educational Campaigns II-5Under-Penetration in CPAP Therapy Promises Significant GrowthProspects II-5OSA Industry Witnesses Consistent M&A Activity II-5

3. COMPETITION AND MARKET STRUCTURE II-7

Resmed and Respironics Dominate Competitive Landscape II-7

Table 1: Global Sleep Apnea Market by Leading Players (2011):

Market Share Breakdown for Philips Respironics, Resmed,

Fisher & Paykel, General Electric Vital Signs, and Others

(includes corresponding Graph/Chart) II-7

Table 2: Global Sleep Apnea Diagnostic Systems Market byLeading Players: Market Share Breakdown for CareFusion Corp.,Philips Respironics, Embla Systems, and Others (includescorresponding Graph/Chart) II-7

4. SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC DEVICES - A SYNOPSIS II-8

Significance of Sleep II-8

Stages of Sleep II-8

Sleep Disorders and Stages of Sleep II-8

Sleep Apnea- Introduction II-8

Forms of Apnea II-9

Central Sleep Apnea II-9

Physiological Effects of CSA II-9

Mixed Apnea II-9

Complex Sleep Apnea II-9

Obstructive Sleep Apnea - An Overview II-10

History II-10

Causes of OSA II-10

Symptoms of OSA II-11

Snoring and OSA II-11

Risks and Complications Associated with Untreated Disorder II-11

Risk Groups II-11

Co-Morbid Conditions II-12

Heart Failure II-12

Hypertension II-12

Diabetes II-12

Fatigue II-12

Complications Associated with Surgery and Medications II-12

Financial Implications of Untreated OSA II-13

Pediatric OSA II-13

5. SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC DEVICES II-14OSA Diagnosis II-14Interpreting AHI II-14AHI of 5 to 15: Mild OSA II-14AHI of 15 to 30: Moderate OSA II-14AHI of more than 30: Severe OSA II-14Sleep Apnea Diagnostic Devices II-14Polysomnography (PSG), and Types of Polysomnographs II-14Clinical/Fixed Polysomnographs II-15Ambulatory Polysomnographs II-15Other Sleep Apnea Diagnostic Devices II-16Screening Devices II-16Actigraphs II-16Sleep Apnea Therapeutic Devices II-16Positive Airway Pressure (PAP) Treatment II-16PAP Devices II-16Continuous Positive Airway Pressure (CPAP) Devices II-16Optional Features Available for CPAP Devices II-17Bilevel Positive Airway Pressure (BiPAP) Devices II-17Auto-titrating Positive Airway Pressure (APAP) Devices II-18Facial Interfaces (Masks and Humidifiers) II-18Alternative Apnea Therapies II-18Oral Appliances II-18Surgical Procedures II-19Tracheostomy II-19Uvulo-palato-pharyngoplasty (UPPP) II-19Mandibular Myotomy II-19Laser Assisted Uvuloplasty (LAUP) II-19Somnoplasty or Radio Frequency (RF) Procedure II-19Pillar Palatal Implant System II-20Other Surgical Therapies II-20Over-the-Counter and Pharmacological Therapies II-20Behavioral and Lifestyle Changes II-20

6. RESEARCH FINDINGS II-21

Research Finds Link Between Sleep Apnea and Heart Risks in

Children II-21

Sleep Disorders Increase Risk for Stroke and Blood Pressure

Patients II-21

Individuals with Sleep Apnea Face Greater Risk of Cardiac

Stress During Air Travel II-21

Sleep Apnea Screening Reduces Risk of Post Operative

Complications II-21

7. PRODUCT LAUNCHES/INTRODUCTIONS II-22US Researchers Develop Novel Sleep Apnea Diagnostic DeviceBased on Ultrasonic Sensors II-22NovaSom Introduces MediTrack® II-22ResMed Launches S9 Series for Sleep Apnea Therapy II-22GE Healthcare Launches MARS® Virtual Sleep Lab II-23Remote Analysis Launches iPhone Sleep Diagnostic Application II-23Circadiance Unveils New Zzzephyr Seal II-23Philips Launches New Sleep Therapy System II-24ImThera Medical Unveils aura6000TM Neurostimulation System II-24Philips Unveils Respironics Products in India II-24CardioNet Introduces SomNet Cardiac Indicator II-24FDA Grants 510(K) Clearance to Dormio Tech II-24Ambu Acquires Sleepmate Technologies II-25CIRCADIANTM Enters into Partnership with Sleep PointeTM forProviding OSA Detection and Cure II-25Medtronic Acquires Restore Medical II-25Blackstone to Take Over Apria Healthcare II-25Nihon Kohden Acquires Neurotronics II-25Medtronic Snaps Up Repose GAHM Product Line of InfluENT Medical II-26GE Healthcare Acquires Vital Signs II-26CleveMed Enters into Collaboration with BIDMC Professor II-26Royal Philips Acquires Respironics II-26Cardinal Health Signs Agreement with SleepNet II-27Nihon Kohden Signs New Agreement with Premier II-27

8. RECENT INDUSTRY ACTIVITY II-28

Dehaier Obtains CE Certification for Sleep Diagnostic Devices

and Air Compressors II-28

CareCentrix Takes Over Sleep Management Solutions II-28

Natus Snaps Up Embla Systems II-28

Graymark Acquires Majority Stake in Village Sleep Center II-29

Continucare Expands Operations through Acquisitions II-29

Healthcare of Today to Acquire IMA and SC X-Ray II-29

Cyberonics Invests in ImThera, Acquires Minority Interest II-30

Graymark Healthcare and North Oak Medical Park Form Partnership II-30

Graymark Healthcare Sells Nocturna East Sleep Centers II-31

Watermark Medical Collaborates with AASM for OSA Diagnostic-

Care Study II-31

AZ-TMJ Sets Up Sleep Apnea Treatment Unit II-31

Phyhealth Launches Subsidiary Phyhealth Sleep Care Centre II-31

WideMed Receives CE Certification for Mobile Sleep Apnea System II-32

WideMed Receives Order from GE Healthcare for Morpheus Hx Devices II-32

SleepQuest Buys Extra WatchPAT Devices from Itamar-Medical II-32

Coliseum Northside Hospital Opens Sleep Disorder Center II-32

Naturs Design Signs Partnership with Intus Healthcare II-33

Graymark Healthcare and Coryell Memorial Healthcare Ink Agreement II-33

Compumedics Obtains FDA Approval for GRAEL™ HD-PSG Sllep System II-33

Covidien Sells Sleep Therapy and Bi-level Products to PH Invest II-33

Embla Snaps Up Covidien's Sleep Diagnostic Business II-33

Graymark Healthcare Signs Joint Venture Agreement with

Oklahoma Heart Hospital II-34

Ethicon Takes Over Acclarent II-34

Siix to Develop Sleep Disorders Tracking Device II-34

Blue Shield and Apria Healthcare Ink Agreement Group II-34

Peak Surgical Inks Distribution Agreement with Medtronic II-34

REM Medical, U.S. Health Works Enter into Partnership II-35

Graymark Healthcare Takes Over somniTech and somniCare II-35

ResMed Takes Over Laboratoires Narval II-35

Curative Medical Snaps Up BEVT II-35

Roadside Medical Clinic + Lab Enters into Joint Venture with

Sleep Pointe II-35

Air Liquide Takes Over Comcare Medical II-36

REM Medical Takes Over Tucson Site of PsyPharma Global II-36

Formation of CareFusion II-36

9. FOCUS ON SELECT PLAYERS II-37Grass Technologies (US) II-37Cadwell Laboratories, Inc. (US) II-37CareFusion Corporation (USA) II-37Compumedics Ltd (Australia) II-38DeVilbiss Healthcare (US) II-38Global Medical Holdings LLC (US) II-39Fisher & Paykel Healthcare Limited (New Zealand) II-39GE Healthcare (US) II-39Vital Signs Inc. (US) II-39Itamar Medical Ltd. (Israel) II-40Invacare Corporation (US) II-40Natus Medical Inc. (US) II-40Bio-Logic (US) II-40Embla Systems, Inc. (US) II-41Stellate Systems, Inc. (Canada) II-41Philips Healthcare (USA) II-41ResMed Inc. (US) II-42Teleflex Medical (US) II-42Weinmann Geräte für Medizin GmbH+CCo. KG (Germany) II-42

10. GLOBAL MARKET PERSPECTIVE II-43

Table 3: World Recent Past, Current & Future Analysis for

Sleep Apnea Diagnostic and Therapeutic Devices by Geographic

Region - US, Japan, Europe and Rest of World Markets

Independently Analyzed with Annual Sales in US$ Million for

Years 2010 through 2018 (includes corresponding Graph/Chart) II-43

Table 4: World Historic Review for Sleep Apnea Diagnostic andTherapeutic Devices by Geographic Region - US, Japan, Europeand Rest of World Markets Independently Analyzed with AnnualSales in US$ Million for Years 2004 through 2009 (includescorresponding Graph/Chart) II-44

Table 5: World 15-Year Perspective for Sleep Apnea Diagnostic

and Therapeutic Devices by Geographic Region - Percentage

Breakdown of Value Sales for US, Japan, Europe and Rest of

World Markets for Years 2004, 2011, and 2018 (includes

corresponding Graph/Chart) II-45

Table 6: World Recent Past, Current & Future Analysis forSleep Apnea Diagnostic Devices by Geographic Region - US,Japan, Europe and Rest of World Markets Independently Analyzedwith Annual Sales in US$ Million for Years 2010 through 2018(includes corresponding Graph/Chart) II-46

Table 7: World Historic Review for Sleep Apnea Diagnostic

Devices by Geographic Region - US, Japan, Europe and Rest of

World Markets Independently Analyzed with Annual Sales in US$

Million for Years 2004 through 2009 (includes corresponding

Graph/Chart) II-47

Table 8: World 15-Year Perspective for Sleep Apnea DiagnosticDevices by Geographic Region - Percentage Breakdown of ValueSales for US, Japan, Europe and Rest of World Markets forYears 2004, 2011, and 2018 (includes correspondingGraph/Chart) II-48

Table 9: World Recent Past, Current & Future Analysis for

Sleep Apnea Diagnostic Devices by Product Segment -

Clinical/Fixed PSG, Ambulatory PSG, and Other Devices

(Screening Devices) Markets Independently Analyzed with Annual

Sales in US$ Million for Years 2010 through 2018 (includes

corresponding Graph/Chart) II-49

Table 10: World Historic Review for Sleep Apnea DiagnosticDevices by Product Segment - Clinical/Fixed PSG, AmbulatoryPSG, and Other Devices (Screening Devices) MarketsIndependently Analyzed with Annual Sales in US$ Million forYears 2004 through 2009 (includes corresponding Graph/Chart) II-50

Table 11: World 15-Year Perspective for Sleep Apnea Diagnostic

Devices by Product Segment - Percentage Breakdown of Value

Sales for Clinical/Fixed PSG, Ambulatory PSG, and Other

Devices (Screening Devices) Markets for Years 2004, 2011, and

2018 (includes corresponding Graph/Chart) II-51

Table 12: World Recent Past, Current & Future Analysis forClinical/Fixed PSG Devices by Geographic Region - US, Japan,Europe and Rest of World Markets Independently Analyzed withAnnual Sales in US$ Million for Years 2010 through 2018(includes corresponding Graph/Chart) II-52

Table 13: World Historic Review for Clinical/Fixed PSG Devices

by Geographic Region - US, Japan, Europe and Rest of World

Markets Independently Analyzed with Annual Sales in US$

Million for Years 2004 through 2009 (includes corresponding

Graph/Chart) II-53

Table 14: World 15-Year Perspective for Clinical/Fixed PSGDevices by Geographic Region - Percentage Breakdown of ValueSales for US, Japan, Europe and Rest of World Markets forYears 2004, 2011, and 2018 (includes correspondingGraph/Chart) II-54

Table 15: World Recent Past, Current & Future Analysis for

Ambulatory PSG Devices by Geographic Region - US, Japan,

Europe and Rest of World Markets Independently Analyzed with

Annual Sales in US$ Million for Years 2010 through 2018

(includes corresponding Graph/Chart) II-55

Table 16: World Historic Review for Ambulatory PSG Devices byGeographic Region - US, Japan, Europe and Rest of WorldMarkets Independently Analyzed with Annual Sales in US$Million for Years 2004 through 2009 (includes correspondingGraph/Chart) II-56

Table 17: World 15-Year Perspective for Ambulatory PSG Devices

by Geographic Region - Percentage Breakdown of Value Sales for

US, Japan, Europe and Rest of World Markets for Years 2004,

2011, and 2018 (includes corresponding Graph/Chart) II-57

Table 18: World Recent Past, Current & Future Analysis forOther Diagnostic Devices (Screening Devices) by GeographicRegion - US, Japan, Europe and Rest of World MarketsIndependently Analyzed with Annual Sales in US$ Million forYears 2010 through 2018 (includes corresponding Graph/Chart) II-58

Table 19: World Historic Review for Other Diagnostic Devices

(Screening Devices) by Geographic Region - US, Japan, Europe

and Rest of World Markets Independently Analyzed with Annual

Sales in US$ Million for Years 2004 through 2009 (includes

corresponding Graph/Chart) II-59

Table 20: World 15-Year Perspective for Other DiagnosticDevices (Screening Devices) by Geographic Region - PercentageBreakdown of Value Sales for US, Japan, Europe and Rest ofWorld Markets for Years 2004, 2011, and 2018 (includescorresponding Graph/Chart) II-60

Table 21: World Recent Past, Current & Future Analysis for

Sleep Apnea Therapeutic Devices by Geographic Region - US,

Japan, Europe and Rest of World Markets Independently Analyzed

with Annual Sales in US$ Million for Years 2010 through 2018

(includes corresponding Graph/Chart) II-61

Table 22: World Historic Review for Sleep Apnea TherapeuticDevices by Geographic Region - US, Japan, Europe and Rest ofWorld Markets Independently Analyzed with Annual Sales in US$Million for Years 2004 through 2009 (includes correspondingGraph/Chart) II-62

Table 23: World 15-Year Perspective for Sleep Apnea

Therapeutic Devices by Geographic Region - Percentage

Breakdown of Value Sales for US, Japan, Europe and Rest of

World Markets for Years 2004, 2011, and 2018 (includes

corresponding Graph/Chart) II-63

Table 24: World Recent Past, Current & Future Analysis forSleep Apnea Therapeutic Devices by Product Segment - PAP, AutoPAP, Bi-Level CPAP, and Facial Interfaces (Masks andHumidifiers) Markets Independently Analyzed with Annual Salesin US$ Million for Years 2010 through 2018 (includescorresponding Graph/Chart) II-64

Table 25: World Historic Review for Sleep Apnea Therapeutic

Devices by Product Segment - CPAP, Auto PAP, Bi-Level PAP, and

Facial Interfaces (Masks and Humidifiers) Markets

Independently Analyzed with Annual Sales in US$ Million for

Years 2004 through 2009 (includes corresponding Graph/Chart) II-65

Table 26: World 15-Year Perspective for Sleep ApneaTherapeutic Devices by Product Segment - Percentage Breakdownof Value Sales for CPAP, Auto PAP, Bi-Level PAP, and FacialInterfaces (Masks and Humidifiers) Markets for Years 2004,2011, and 2018 (includes corresponding Graph/Chart) II-66

Table 27: World Recent Past, Current & Future Analysis for

CPAP Devices by Geographic Region - US, Japan, Europe and Rest

of World Markets Independently Analyzed with Annual Sales in

US$ Million for Years 2010 through 2018 (includes

corresponding Graph/Chart) II-67

Table 28: World Historic Review for CPAP Devices by GeographicRegion - US, Japan, Europe and Rest of World MarketsIndependently Analyzed with Annual Sales in US$ Million forYears 2004 through 2009 (includes corresponding Graph/Chart) II-68

Table 29: World 15-Year Perspective for CPAP Devices by

Geographic Region - Percentage Breakdown of Value Sales for

US, Japan, Europe and Rest of World Markets for Years 2004,

2011, and 2018 (includes corresponding Graph/Chart) II-69

Table 30: World Recent Past, Current & Future Analysis forAuto PAP Devices by Geographic Region - US, Japan, Europe andRest of World Markets Independently Analyzed with Annual Salesin US$ Million for Years 2010 through 2018 (includescorresponding Graph/Chart) II-70

Table 31: World Historic Review for Auto PAP Devices by

Geographic Region - US, Japan, Europe and Rest of World

Markets Independently Analyzed with Annual Sales in US$

Million for Years 2004 through 2009 (includes corresponding

Graph/Chart) II-71

Table 32: World 15-Year Perspective for Auto PAP Devices byGeographic Region - Percentage Breakdown of Value Sales forUS, Japan, Europe and Rest of World Markets for Years 2004,2011, and 2018 (includes corresponding Graph/Chart) II-72

Table 33: World Recent Past, Current & Future Analysis for

Bi-Level PAP Devices by Geographic Region - US, Japan, Europe

and Rest of World Markets Independently Analyzed with Annual

Sales in US$ Million for Years 2010 through 2018 (includes

corresponding Graph/Chart) II-73

Table 34: World Historic Review for Bi-Level PAP Devices byGeographic Region - US, Japan, Europe and Rest of WorldMarkets Independently Analyzed with Annual Sales in US$Million for Years 2004 through 2009 (includes correspondingGraph/Chart) II-74

Table 35: World 15-Year Perspective for Bi-Level PAP Devices

by Geographic Region - Percentage Breakdown of Value Sales for

US, Japan, Europe and Rest of World Markets for Years 2004,

2011, and 2018 (includes corresponding Graph/Chart) II-75

Table 36: World Recent Past, Current & Future Analysis forFacial Interfaces (Masks and Humidifiers) by Geographic Region -US, Japan, Europe and Rest of World Markets IndependentlyAnalyzed with Annual Sales in US$ Million for Years 2010through 2018 (includes corresponding Graph/Chart) II-76

Table 37: World Historic Review for Facial Interfaces (Masks

and Humidifiers) by Geographic Region - US, Japan, Europe and

Rest of World Markets Independently Analyzed with Annual Sales

in US$ Million for Years 2004 through 2009 (includes

corresponding Graph/Chart) II-77

Table 38: World 15-Year Perspective for Facial Interfaces(Masks and Humidifiers) by Geographic Region - PercentageBreakdown of Value Sales for US, Japan, Europe and Rest ofWorld Markets for Years 2004, 2011, and 2018 (includescorresponding Graph/Chart) II-78III. MARKET

1. THE UNITED STATES III-1

A.Market Analysis III-1

Sleep Disorders: Factsheet III-1

Sleep Apnea in the US: A Demographic Outline III-1

Sleep Apnea Devices: Overview III-1

Sleep Apnea Market Flourishes under the Influence of Myriad

Factors III-2

Home Sleep Testing (HST) III-2

Pricing Trends III-3

Pricing Erosion on the Rise III-3

Premium Products to Command Higher Prices III-3

Reimbursement Scenario III-3

Reimbursement Revisions to Boost OSA Market III-3

Home Sleep Tests Pose Significant Risk for Clinical

Polysomnographs III-4

Reimbursement Criteria for Sleep Apnea Diagnostic and

Therapy Devices III-4

Table 39: Reimbursement Rates of CPAP Devices: 2010 (In

US$) III-5

Average Replacement Schedules III-6

Competitive Landscape III-6

Table 40: US Market for Sleep Therapy (2011) - Percentage

Breakdown of Revenues for Respironics, ResMed, Fisher &

Paykel, and Others III-6

Distribution of Sleep Apnea Devices III-6

A Review of the Sleep Service Providers Market III-7

Greater Awareness Drives More Number of Sleep Labs III-7

Table 41: Increasing Number of Sleep Facilities in the US

(includes corresponding Graph/Chart) III-7

Changeover of the Sleep Lab III-8

Inadequate Sleep Labs - a Bottleneck for Diagnosis of OSA III-8

Inadequate Sleep Labs Surge Development of Portable Sleep

Monitoring III-8

DME Market for Sleep Apnea Devices III-9

Table 42: US Market for CPAP Devices (2010) - Percentage

Breakdown of Value Sales by Durable Medical Equipment (DME)

Suppliers for Apria Healthcare Group, Lincare Holdings Inc,

National Companies and Local Operators (includes

corresponding Graph/Chart) III-9

Strategic Corporate Developments III-9

Focus on Select Players III-13

B.Market Analytics III-18

Table 43: The US Recent Past, Current & Future Analysis for

Sleep Apnea Diagnostic and Therapeutic Devices by Product

Segment - Diagnostic Devices (Clinical/Fixed PSG, Ambulatory

PSG, and Others (Screening Devices)), and Therapeutic

Devices (CPAP, Auto PAP, Bi-Level PAP, and Facial Interfaces

(Masks and Humidifiers)) Markets Independently Analyzed with

Annual Sales in US$ Million for Years 2010 through 2018

(includes corresponding Graph/Chart) III-18

Table 44: The US Historic Review for Sleep Apnea Diagnosticand Therapeutic Devices by Product Segment - DiagnosticDevices (Clinical/Fixed PSG, Ambulatory PSG, and Others(Screening Devices)), and Therapeutic Devices (CPAP ,AutoPAP, Bi-Level PAP, and Facial Interfaces (Masks andHumidifiers)) Markets Independently Analyzed with AnnualSales in US$ Million for Years 2004 through 2009 (includescorresponding Graph/Chart) III-19

Table 45: The US 15-Year Perspective for Sleep Apnea

Diagnostic and Therapeutic Devices by Product Segment -

Percentage Breakdown of Value Sales for Diagnostic Devices

(Clinical/ Fixed PSG, Ambulatory PSG, and Others (Screening

Devices)), and Therapeutic Devices (CPAP, Auto PAP,Bi-Level

PAP, and Facial Interfaces (Masks and Humidifiers)) Markets

for Years 2004, 2011, and 2018 (includes corresponding

Graph/Chart) III-20

2. JAPAN III-21A.Market Analysis III-21Japanese Continuous-Positive Airway Pressure (CPAP) Market III-21B.Market Analytics III-22Table 46: Japanese Recent Past, Current & Future Analysisfor Sleep Apnea Diagnostic and Therapeutic Devices byProduct Segment - Diagnostic Devices (Clinical/Fixed PSG,Ambulatory PSG, and Others (Screening Devices)), andTherapeutic Devices (CPAP, Auto PAP, Bi-Level PAP, andFacial Interfaces (Masks and Humidifiers)) MarketsIndependently Analyzed with Annual Sales in US$ Million forYears 2010 through 2018 (includes corresponding Graph/Chart) III-22

Table 47: Japanese Historic Review for Sleep Apnea

Diagnostic and Therapeutic Devices by Product Segment -

Diagnostic Devices (Clinical/Fixed PSG, Ambulatory PSG, and

Others (Screening Devices)), and Therapeutic Devices (CPAP,

Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks and

Humidifiers)) Markets Independently Analyzed with Annual

Sales in US$ Million for Years 2004 through 2009 (includes

corresponding Graph/Chart) III-23

Table 48: Japanese 15-Year Perspective for Sleep ApneaDiagnostic and Therapeutic Devices by Product Segment -Diagnostic Devices (Clinical/Fixed PSG, Ambulatory PSG, andOthers (Screening Devices)), and Therapeutic Devices (CPAP,Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks andHumidifiers)) Markets for Years 2004, 2011, and 2018(includes corresponding Graph/Chart) III-24

3. EUROPE III-25

A.Market Analysis III-25

Sleep Apnea Diagnostics - Overview III-25

Trends & Issues III-26

Ambulatory PSGs Gaining over Clinical PSGs III-26

Insufficient Funds & Improper Distribution Endanger Growth

of Sleep Apnea Diagnostics III-26

Strategic Corporate Initiatives III-26

B.Market Analytics III-28

Table 49: European Recent Past, Current & Future Analysis

for Sleep Apnea Diagnostic and Therapeutic Devices by

Geographic Region - France, Germany, Italy, UK, Spain and

Rest of Europe Markets Independently Analyzed with Annual

Sales in US$ Million for Years 2010 through 2018 (includes

corresponding Graph/Chart) III-28

Table 50: European Historic Review for Sleep ApneaDiagnostic and Therapeutic Devices by Geographic Region -France, Germany, Italy, UK, Spain and Rest of Europe MarketsIndependently Analyzed with Annual Sales in US$ Million forYears 2004 through 2009 (includes corresponding Graph/Chart) III-29

Table 51: European 15-Year Perspective for Sleep Apnea

Diagnostic and Therapeutic Devices by Geographic Region -

Percentage Breakdown of Value Sales for France, Germany,

Italy, UK, Spain and Rest of Europe Markets for Years 2004,

2011, and 2018 (includes corresponding Graph/Chart) III-30

Table 52: European Recent Past, Current & Future Analysisfor Sleep Apnea Diagnostic and Therapeutic Devices byProduct Segment - Diagnostic Devices (Clinical/Fixed PSG,Ambulatory PSG, and Others (Screening Devices)), andTherapeutic Devices (CPAP, Auto PAP, Bi-Level PAP, andFacial Interfaces (Masks and Humidifiers)) MarketsIndependently Analyzed with Annual Sales in US$ Million forYears 2010 through 2018 (includes corresponding Graph/Chart) III-31

Table 53: European Historic Review for Sleep Apnea

Diagnostic and Therapeutic Devices by Product Segment -

Diagnostic Devices (Clinical/Fixed PSG, Ambulatory PSG, and

Others (Screening Devices)), and Therapeutic Devices (CPAP,

Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks and

Humidifiers)) Markets Independently Analyzed with Annual

Sales in US$ Million for Years 2004 through 2009 (includes

corresponding Graph/Chart) III-32

Table 54: European 15-Year Perspective for Sleep ApneaDiagnostic and Therapeutic Devices by Product Segment -Percentage Breakdown of Value Sales for Diagnostic Devices(Clinical/ Fixed PSG, Ambulatory PSG, and Others (ScreeningDevices)), and Therapeutic Devices (CPAP, Auto PAP, Bi-LevelPAP, and Facial Interfaces (Masks and Humidifiers)) Marketsfor Years 2004, 2011, and 2018 (includes correspondingGraph/Chart) III-33

3a. FRANCE III-34

A.Market Analysis III-34

Outlook III-34

B.Market Analytics III-35

Table 55: French Recent Past, Current & Future Analysis for

Sleep Apnea Diagnostic and Therapeutic Devices by Product

Segment - Sleep Apnea Diagnostic Devices and Sleep Apnea

Therapeutic Devices Markets Independently Analyzed with

Annual Sales in US$ Million for Years 2010 through 2018

(includes corresponding Graph/Chart) III-35

Table 56: French Historic Review for Sleep Apnea Diagnosticand Therapeutic Devices by Product Segment - Sleep ApneaDiagnostic Devices and Sleep Apnea Therapeutic DevicesMarkets Independently Analyzed with Annual Sales in US$Million for Years 2004 through 2009 (includes correspondingGraph/Chart) III-36

Table 57: French 15-Year Perspective for Sleep Apnea

Diagnostic and Therapeutic Devices by Product Segment -

Percentage Breakdown of Value Sales for Sleep Apnea

Diagnostic Devices and Sleep Apnea Therapeutic Devices

Markets for Years 2004, 2011, and 2018 (includes

corresponding Graph/Chart) III-37

3b. GERMANY III-38A.Market Analysis III-38Weinmann Geräte für Medizin GmbH+CCo. KG - A Key Player III-38B.Market Analytics III-39Table 58: German Recent Past, Current & Future Analysis forSleep Apnea Diagnostic and Therapeutic Devices by ProductSegment - Sleep Apnea Diagnostic Devices and Sleep ApneaTherapeutic Devices Markets Independently Analyzed withAnnual Sales in US$ Million for Years 2010 through 2018(includes corresponding Graph/Chart) III-39

Table 59: German Historic Review for Sleep Apnea Diagnostic

and Therapeutic Devices by Product Segment - Sleep Apnea

Diagnostic Devices and Sleep Apnea Therapeutic Devices

Markets Independently Analyzed with Annual Sales in US$

Million for Years 2004 through 2009 (includes corresponding

Graph/Chart) III-40

Table 60: German 15-Year Perspective for Sleep ApneaDiagnostic and Therapeutic Devices by Product Segment -Percentage Breakdown of Value Sales for Sleep ApneaDiagnostic Devices and Sleep Apnea Therapeutic DevicesMarkets for Years 2004, 2011, and 2018 (includescorresponding Graph/Chart) III-41

3c. ITALY III-42

Market Analysis III-42

Table 61: Italian Recent Past, Current & Future Analysis for

Sleep Apnea Diagnostic and Therapeutic Devices by Product

Segment - Sleep Apnea Diagnostic Devices and Sleep Apnea

Therapeutic Devices Markets Independently Analyzed with

Annual Sales in US$ Million for Years 2010 through 2018

(includes corresponding Graph/Chart) III-42

Table 62: Italian Historic Review for Sleep Apnea Diagnosticand Therapeutic Devices by Product Segment - Sleep ApneaDiagnostic Devices and Sleep Apnea Therapeutic DevicesMarkets Independently Analyzed with Annual Sales in US$Million for Years 2004 through 2009 (includes correspondingGraph/Chart) III-43

Table 63: Italian 15-Year Perspective for Sleep Apnea

Diagnostic and Therapeutic Devices by Product Segment -

Percentage Breakdown of Value Sales for Sleep Apnea

Diagnostic Devices and Sleep Apnea Therapeutic Devices

Markets for Years 2004, 2011, and 2018 (includes

corresponding Graph/Chart) III-44

3d. THE UNITED KINGDOM III-45A.Market Analysis III-45Sleep Disorder: Factsheet III-45Current and Future Analysis III-45B.Market Analytics III-46Table 64: The UK Recent Past, Current & Future Analysis forSleep Apnea Diagnostic and Therapeutic Devices by ProductSegment - Sleep Apnea Diagnostic Devices and Sleep ApneaTherapeutic Devices Markets Independently Analyzed withAnnual Sales in US$ Million for Years 2010 through 2018(includes corresponding Graph/Chart) III-46

Table 65: The UK Historic Review for Sleep Apnea Diagnostic

and Therapeutic Devices by Product Segment - Sleep Apnea

Diagnostic Devices and Sleep Apnea Therapeutic Devices

Markets Independently Analyzed with Annual Sales in US$

Million for Years 2004 through 2009 (includes corresponding

Graph/Chart) III-47

Table 66: The UK 15-Year Perspective for Sleep ApneaDiagnostic and Therapeutic Devices by Product Segment -Percentage Breakdown of Value Sales for Sleep ApneaDiagnostic Devices and Sleep Apnea Therapeutic DevicesMarkets for Years 2004, 2011, and 2018 (includescorresponding Graph/Chart) III-48

3e. SPAIN III-49

Market Analysis III-49

Table 67: Spanish Recent Past, Current & Future Analysis for

Sleep Apnea Diagnostic and Therapeutic Devices by Product

Segment - Sleep Apnea Diagnostic Devices and Sleep Apnea

Therapeutic Devices Markets Independently Analyzed with

Annual Sales in US$ Million for Years 2010 through 2018

(includes corresponding Graph/Chart) III-49

Table 68: Spanish Historic Review for Sleep Apnea Diagnosticand Therapeutic Devices by Product Segment - Sleep ApneaDiagnostic Devices and Sleep Apnea Therapeutic DevicesMarkets Independently Analyzed with Annual Sales in US$Million for Years 2004 through 2009 (includes correspondingGraph/Chart) III-50

Table 69: Spanish 15-Year Perspective for Sleep Apnea

Diagnostic and Therapeutic Devices by Product Segment -

Percentage Breakdown of Value Sales for Sleep Apnea

Diagnostic Devices and Sleep Apnea Therapeutic Devices

Markets for Years 2004, 2011, and 2018 (includes

corresponding Graph/Chart) III-51

3f. REST OF EUROPE III-52Market Analysis III-52Table 70: Rest of European Recent Past, Current & FutureAnalysis for Sleep Apnea Diagnostic and Therapeutic Devicesby Product Segment - Sleep Apnea Diagnostic Devices andSleep Apnea Therapeutic Devices Markets IndependentlyAnalyzed with Annual Sales in US$ Million for Years 2010through 2018 (includes corresponding Graph/Chart) III-52

Table 71: Rest of European Historic Review for Sleep Apnea

Diagnostic and Therapeutic Devices by Product Segment -

Sleep Apnea Diagnostic Devices and Sleep Apnea Therapeutic

Devices Markets Independently Analyzed with Annual Sales in

US$ Million for Years 2004 through 2009 (includes

corresponding Graph/Chart) III-53

Table 72: Rest of European 15-Year Perspective for SleepApnea Diagnostic and Therapeutic Devices by Product Segment -Percentage Breakdown of Value Sales for Sleep ApneaDiagnostic Devices and Sleep Apnea Therapeutic DevicesMarkets for Years 2004, 2011, and 2018 (includescorresponding Graph/Chart) III-54

4. REST OF WORLD III-55

A.Market Analysis III-55

Outlook III-55

Overview of Select Markets III-55

Australia III-55

Significant Demand for Sleep Apnea Therapeutic Devices III-55

Table 73: Australian Sleep Apnea Therapeutic Devices

Market (2011) - Percentage Breakdown of Value Sales for

ResMed, Respironics, Fisher & Paykel and Others (includes

corresponding Graph/Chart) III-56

Distribution III-56

Table 74: Australian Sleep Apnea Therapeutic Devices Market

by Distribution Channel: 2011 (includes corresponding

Graph/Chart) III-56

India - A High Potential Market III-56

Focus on Select Players III-57

B.Market Analytics III-59

Table 75: Rest of World Recent Past, Current & Future

Analysis for Sleep Apnea Diagnostic and Therapeutic Devices

by Product Segment - Diagnostic Devices (Clinical/Fixed PSG,

Ambulatory PSG, and Others (Screening Devices)), and

Therapeutic Devices (CPAP, Auto PAP, Bi-Level PAP, and

Facial Interfaces (Masks and Humidifiers)) Markets

Independently Analyzed with Annual Sales in US$ Million for

Years 2010 through 2018 (includes corresponding Graph/Chart) III-59

Table 76: Rest of World Historic Review for Sleep ApneaDiagnostic and Therapeutic Devices by Product Segment -Diagnostic Devices (Clinical/ Fixed PSG, Ambulatory PSG, andOthers (Screening Devices)), and Therapeutic Devices (CPAP,Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks andHumidifiers)) Markets Independently Analyzed with AnnualSales in US$ Million for Years 2004 through 2009 (includescorresponding Graph/Chart) III-60

Table 77: Rest of World 15-Year Perspective for Sleep Apnea

Diagnostic and Therapeutic Devices by Product Segment -

Percentage Breakdown of Value Sales for Diagnostic Devices

(Clinical/Fixed PSG, Ambulatory PSG, and Others (Screening

Devices)), and Therapeutic Devices (CPAP, Auto PAP, Bi-Level

PAP, and Facial Interfaces (Masks and Humidifiers)) Markets

for Years 2004, 2011, and 2018 (includes corresponding

Graph/Chart) III-61

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 68 (including Divisions/Subsidiaries - 106)

The United States (51)Canada (4)Japan (2)Europe (31)- France (4)- Germany (8)- The United Kingdom (5)- Italy (2)- Spain (3)- Rest of Europe (9)Asia-Pacific (Excluding Japan) (13)Latin America (2)Middle East (3)

To order this report:Pathology Industry: Global Sleep Apnea Diagnostic And Therapeutic Devices Industry

Nicolas Bombourg

Reportlinker

Email: [email protected]

US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

@ThingsExpo Stories
"Evatronix provides design services to companies that need to integrate the IoT technology in their products but they don't necessarily have the expertise, knowledge and design team to do so," explained Adam Morawiec, VP of Business Development at Evatronix, in this SYS-CON.tv interview at @ThingsExpo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
Smart cities have the potential to change our lives at so many levels for citizens: less pollution, reduced parking obstacles, better health, education and more energy savings. Real-time data streaming and the Internet of Things (IoT) possess the power to turn this vision into a reality. However, most organizations today are building their data infrastructure to focus solely on addressing immediate business needs vs. a platform capable of quickly adapting emerging technologies to address future ...
In his Opening Keynote at 21st Cloud Expo, John Considine, General Manager of IBM Cloud Infrastructure, led attendees through the exciting evolution of the cloud. He looked at this major disruption from the perspective of technology, business models, and what this means for enterprises of all sizes. John Considine is General Manager of Cloud Infrastructure Services at IBM. In that role he is responsible for leading IBM’s public cloud infrastructure including strategy, development, and offering m...
Product connectivity goes hand and hand these days with increased use of personal data. New IoT devices are becoming more personalized than ever before. In his session at 22nd Cloud Expo | DXWorld Expo, Nicolas Fierro, CEO of MIMIR Blockchain Solutions, will discuss how in order to protect your data and privacy, IoT applications need to embrace Blockchain technology for a new level of product security never before seen - or needed.
The 22nd International Cloud Expo | 1st DXWorld Expo has announced that its Call for Papers is open. Cloud Expo | DXWorld Expo, to be held June 5-7, 2018, at the Javits Center in New York, NY, brings together Cloud Computing, Digital Transformation, Big Data, Internet of Things, DevOps, Machine Learning and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding busin...
SYS-CON Events announced today that Synametrics Technologies will exhibit at SYS-CON's 22nd International Cloud Expo®, which will take place on June 5-7, 2018, at the Javits Center in New York, NY. Synametrics Technologies is a privately held company based in Plainsboro, New Jersey that has been providing solutions for the developer community since 1997. Based on the success of its initial product offerings such as WinSQL, Xeams, SynaMan and Syncrify, Synametrics continues to create and hone inn...
Digital Transformation (DX) is not a "one-size-fits all" strategy. Each organization needs to develop its own unique, long-term DX plan. It must do so by realizing that we now live in a data-driven age, and that technologies such as Cloud Computing, Big Data, the IoT, Cognitive Computing, and Blockchain are only tools. In her general session at 21st Cloud Expo, Rebecca Wanta explained how the strategy must focus on DX and include a commitment from top management to create great IT jobs, monitor ...
Cloud Expo | DXWorld Expo have announced the conference tracks for Cloud Expo 2018. Cloud Expo will be held June 5-7, 2018, at the Javits Center in New York City, and November 6-8, 2018, at the Santa Clara Convention Center, Santa Clara, CA. Digital Transformation (DX) is a major focus with the introduction of DX Expo within the program. Successful transformation requires a laser focus on being data-driven and on using all the tools available that enable transformation if they plan to survive ov...
A strange thing is happening along the way to the Internet of Things, namely far too many devices to work with and manage. It has become clear that we'll need much higher efficiency user experiences that can allow us to more easily and scalably work with the thousands of devices that will soon be in each of our lives. Enter the conversational interface revolution, combining bots we can literally talk with, gesture to, and even direct with our thoughts, with embedded artificial intelligence, whic...
Recently, REAN Cloud built a digital concierge for a North Carolina hospital that had observed that most patient call button questions were repetitive. In addition, the paper-based process used to measure patient health metrics was laborious, not in real-time and sometimes error-prone. In their session at 21st Cloud Expo, Sean Finnerty, Executive Director, Practice Lead, Health Care & Life Science at REAN Cloud, and Dr. S.P.T. Krishnan, Principal Architect at REAN Cloud, discussed how they built...
Recently, WebRTC has a lot of eyes from market. The use cases of WebRTC are expanding - video chat, online education, online health care etc. Not only for human-to-human communication, but also IoT use cases such as machine to human use cases can be seen recently. One of the typical use-case is remote camera monitoring. With WebRTC, people can have interoperability and flexibility for deploying monitoring service. However, the benefit of WebRTC for IoT is not only its convenience and interopera...
With tough new regulations coming to Europe on data privacy in May 2018, Calligo will explain why in reality the effect is global and transforms how you consider critical data. EU GDPR fundamentally rewrites the rules for cloud, Big Data and IoT. In his session at 21st Cloud Expo, Adam Ryan, Vice President and General Manager EMEA at Calligo, examined the regulations and provided insight on how it affects technology, challenges the established rules and will usher in new levels of diligence arou...
SYS-CON Events announced today that Evatronix will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Evatronix SA offers comprehensive solutions in the design and implementation of electronic systems, in CAD / CAM deployment, and also is a designer and manufacturer of advanced 3D scanners for professional applications.
To get the most out of their data, successful companies are not focusing on queries and data lakes, they are actively integrating analytics into their operations with a data-first application development approach. Real-time adjustments to improve revenues, reduce costs, or mitigate risk rely on applications that minimize latency on a variety of data sources. In his session at @BigDataExpo, Jack Norris, Senior Vice President, Data and Applications at MapR Technologies, reviewed best practices to ...
No hype cycles or predictions of a gazillion things here. IoT is here. You get it. You know your business and have great ideas for a business transformation strategy. What comes next? Time to make it happen. In his session at @ThingsExpo, Jay Mason, an Associate Partner of Analytics, IoT & Cybersecurity at M&S Consulting, presented a step-by-step plan to develop your technology implementation strategy. He also discussed the evaluation of communication standards and IoT messaging protocols, data...
In his session at 21st Cloud Expo, Raju Shreewastava, founder of Big Data Trunk, provided a fun and simple way to introduce Machine Leaning to anyone and everyone. He solved a machine learning problem and demonstrated an easy way to be able to do machine learning without even coding. Raju Shreewastava is the founder of Big Data Trunk (www.BigDataTrunk.com), a Big Data Training and consulting firm with offices in the United States. He previously led the data warehouse/business intelligence and B...
"Digital transformation - what we knew about it in the past has been redefined. Automation is going to play such a huge role in that because the culture, the technology, and the business operations are being shifted now," stated Brian Boeggeman, VP of Alliances & Partnerships at Ayehu, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
Nordstrom is transforming the way that they do business and the cloud is the key to enabling speed and hyper personalized customer experiences. In his session at 21st Cloud Expo, Ken Schow, VP of Engineering at Nordstrom, discussed some of the key learnings and common pitfalls of large enterprises moving to the cloud. This includes strategies around choosing a cloud provider(s), architecture, and lessons learned. In addition, he covered some of the best practices for structured team migration an...
22nd International Cloud Expo, taking place June 5-7, 2018, at the Javits Center in New York City, NY, and co-located with the 1st DXWorld Expo will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud ...
22nd International Cloud Expo, taking place June 5-7, 2018, at the Javits Center in New York City, NY, and co-located with the 1st DXWorld Expo will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud ...